What is Mark Leibenhaut's specialty?

Mark Leibenhaut (NPI 1932108263) is a Medicare-billing provider whose primary specialty is Radiation Oncology in Sacramento, CA.

Where does Mark Leibenhaut practice?

Mark Leibenhaut practices in Sacramento, CA, based on the location reported in the CMS Medicare provider datasets for NPI 1932108263.

How much does Medicare pay Mark Leibenhaut?

Medicare Part B utilization, prescribing (Part D), MIPS quality scores, and industry payments for Mark Leibenhaut (NPI 1932108263) are detailed on this CareTrace profile.

PROVIDER PROFILE · NPI 1932108263

Mark Leibenhaut

Radiation OncologySacramento, CAI

MEDICARE UTILIZATION · PART B · 2024

No data available for this provider in 2024.

PRESCRIBING · PART D · 2024

Total Rx claims

Beneficiaries

—

Total drug cost

—

Distinct drugs

Brand share

0.0%

Top prescribed drugs

Omeprazole13 claims

Pravastatin Sodium13 claims

QUALITY · MIPS · 2024

No data available for this provider in 2024.

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

No data available for this provider in 2024.

REFERRAL NETWORK

Where Mark Leibenhaut's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 9 inbound referrers · 0 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
Harvey Wolkov Radiation Oncology · Sacramento, CA	193	6,305
ANDRAS, ELLIS	79	354
Ucsf Dermatopathology Service Clinical Laboratory · San Francisco, CA	68	157
Brian Goldsmith Radiation Oncology · Sacramento, CA	24	511
SUPLICA, JEFFREY	19	500
Nitin Rohatgi Hematology · Sacramento, CA	16	93
BISSELL, KAREN	15	27
Brian Golden Urology · Sacramento, CA	13	127
POUNDS, THOMAS	12	25

Refers patients to

Outbound — where patients go next

No outbound pairs above the suppression threshold.

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history